Tony Goodman
CIK 1717971 · Chief Operating Officer · last filed 2026-04-09
Tony Goodman is a Chief Operating Officer who has filed 9 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for ADIL, was dated Apr 9, 2026. Current disclosed insider exposure totals $79.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$79.0K
2
9
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ADIL | Chief Operating Officer | 26,523 | $2.98 | $79.0K | $0 | 3 | 2026-04-09 |
| ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Director | 8,755 | $0.00 | $8 | $0 | 6 | 2023-05-25 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-09 | ADIL | Grant (A) | +26,510 | $0 | EDGAR |
| 2025-06-02 | ADIL | Grant (A) | — | $0 | EDGAR |
| 2024-03-27 | ADIL | Grant (A) | — | $0 | EDGAR |
| 2023-05-25 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-28 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-25 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-10 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-05 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-08-02 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Buy (P) | +7,000 | $0 | EDGAR |